APLIF OTC
Appili Therapeutics Inc
1W: -22.2%
1M: +0.0%
3M: -34.5%
YTD: -53.3%
1Y: -50.0%
3Y: -82.5%
5Y: -98.8%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$1M
-259.7% ▼
Capital Expenditures
$4
+99.8% ▲
5Y CAGR: -67.1%
Free Cash Flow
-$1M
-260.2% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$1M
-201.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$14M | -$25M | -$4M | -$3M | -$4M |
| Depreciation & Amort. | $15K | $13K | $14K | $13K | $8K |
| Stock-Based Comp. | $2M | $875K | $191K | $118K | $0 |
| Change in Working Capital | $2M | $2M | -$999K | -$226K | $2M |
| Other Non-Cash Items | $23K | $2M | $2M | $4M | $755K |
| Operating Cash Flow | -$11M | -$19M | -$2M | $869K | -$1M |
| — Investing Activities — | |||||
| Capital Expenditures | -$8K | -$3K | -$30K | -$2K | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | -$20M | $0 | $0 | $0 | $0 |
| Investment Sales | $15M | $5M | $0 | $0 | $0 |
| Other Investing | $5M | $3K | $654 | $0 | $0 |
| Investing Cash Flow | -$5M | $5M | -$29K | -$2K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $4M | $2M | $204K | $258K | -$58K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $8M | $280K | -$82K | -$65K | $0 |
| Financing Cash Flow | $17M | $10M | $122K | $194K | $198K |
| Net Change in Cash | $553K | -$4M | -$2M | $1M | -$1M |
| Cash End of Period | $11M | $7M | $94K | $1M | $40K |
| Free Cash Flow | -$11M | -$19M | -$2M | $866K | -$1M |